Cost-effectiveness of esketamine nasal spray compared to intravenous ketamine for patients with treatment-resistant depression in the US utilizing clinical trial efficacy and real-world effectiveness estimates
Madeline Brendle, Reid Robison, Daniel C. Malone
Topics & Concepts
KetamineMedicineTreatment-resistant depressionCost effectivenessClinical trialNasal sprayRandomized controlled trialAnesthesiaInternal medicineMajor depressive disorderPharmacologyNasal administrationAmygdalaRisk analysis (engineering)Treatment of Major DepressionMental Health Treatment and AccessDigital Mental Health Interventions